IBCL-015 The Financial Toxicity of FDA-Drugs Approved for Malignant Hematology

Mahran Shoukier, Mycal Casey, Jorge Cortes

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'IBCL-015 The Financial Toxicity of FDA-Drugs Approved for Malignant Hematology'. Together they form a unique fingerprint.

Medicine & Life Sciences